Jerusalem, Israel

Guy Levi


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guy Levi: Innovator in Transgenic Microalgae Technology

Introduction

Guy Levi is a prominent inventor based in Jerusalem, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic microalgae. With a total of 2 patents, his work focuses on the oral delivery of biologically active proteins through innovative methods.

Latest Patents

Guy Levi's latest patents include groundbreaking research on transgenic microalgae. His patents detail the use of transgenic microalgae expressing at least one exogenous biologically active protein. These protein-expressing microalgae are designed for the oral delivery of biologically active proteins to target organisms in their intact and functional forms. The exogenous proteins expressed in the algae are characterized by their biological activity, which exerts specific beneficial effects on the subjects consuming the algae. The applications of these transgenic microalgae extend to animal food for both aquatic and land animals, as well as food supplements for human healthcare.

Career Highlights

Throughout his career, Guy Levi has worked with notable companies such as Transalgae Israel Ltd. and Transalgae Ltd. His innovative approach and dedication to advancing biotechnology have positioned him as a key figure in his field.

Collaborations

Guy Levi has collaborated with several professionals, including Shiri Moshitzky and Doron Eisenstadt. These partnerships have contributed to the success of his projects and the advancement of transgenic microalgae technology.

Conclusion

Guy Levi's work in transgenic microalgae represents a significant advancement in biotechnology, with promising applications for both animal welfare and human health. His innovative patents and collaborations highlight his commitment to improving the delivery of biologically active proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…